| Assessment of minimal residual disease in standard-risk AML A Ivey, RK Hills, MA Simpson, JV Jovanovic, A Gilkes, A Grech, Y Patel, ... New England Journal of Medicine 374 (5), 422-433, 2016 | 866 | 2016 |
| Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations AJ Bench, HE White, L Foroni, AL Godfrey, G Gerrard, S Akiki, A Awan, ... British journal of haematology 160 (1), 25-34, 2013 | 134 | 2013 |
| Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative … JV Jovanovic, A Ivey, AM Vannucchi, E Lippert, E Oppliger Leibundgut, ... Leukemia 27 (10), 2032-2039, 2013 | 124 | 2013 |
| A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR H White, L Deprez, P Corbisier, V Hall, F Lin, S Mazoua, S Trapmann, ... Leukemia 29 (2), 369-376, 2015 | 96 | 2015 |
| The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants A Rio-Machin, T Vulliamy, N Hug, A Walne, K Tawana, S Cardoso, ... Nature communications 11 (1), 1044, 2020 | 93 | 2020 |
| RT-qPCR and RT-digital PCR: a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemia M Alikian, AS Whale, S Akiki, K Piechocki, C Torrado, T Myint, S Cowen, ... Clinical chemistry 63 (2), 525-531, 2017 | 81 | 2017 |
| Chronic FLT3-ITD signaling in acute myeloid leukemia is connected to a specific chromatin signature P Cauchy, SR James, J Zacarias-Cabeza, A Ptasinska, MR Imperato, ... Cell reports 12 (5), 821-836, 2015 | 79 | 2015 |
| Benign monoclonal expansion of CD8+ lymphocytes in HIV infection PR Smith, JD Cavenagh, T Milne, D Howe, SJ Wilkes, P Sinnott, ... Journal of clinical pathology 53 (3), 177-181, 2000 | 72 | 2000 |
| Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia SR Cardoso, G Ryan, AJ Walne, A Ellison, R Lowe, H Tummala, ... Leukemia 30 (10), 2083-2086, 2016 | 71 | 2016 |
| Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) by real-time quantitative … H Pfeifer, G Cazzaniga, VHJ Van der Velden, JM Cayuela, B Schäfer, ... Leukemia 33 (8), 1910-1922, 2019 | 68 | 2019 |
| Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale NCP Cross, HE White, T Ernst, L Welden, C Dietz, G Saglio, FX Mahon, ... Leukemia 30 (9), 1844-1852, 2016 | 58 | 2016 |
| Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations M Griffiths, J Mason, M Rindl, S Akiki, D McMullan, V Stinton, H Powell, ... Leukemia 19 (12), 2355-2358, 2005 | 48 | 2005 |
| NUP98‐NSD1 fusion in association with FLT3‐ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for … S Akiki, SA Dyer, D Grimwade, A Ivey, N Abou‐Zeid, J Borrow, S Jeffries, ... Genes, Chromosomes and Cancer 52 (11), 1053-1064, 2013 | 45 | 2013 |
| Clinical experience of clozapine-induced neutropenia in the UK: laboratory investigation using liquid culture systems and immunofluorocytometry PA Veys, S Wilkes, S Shah, R Noyelle, AV Hoffbrand Drug Safety 7, 26-32, 1992 | 36 | 1992 |
| Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia C Bradbury, AE Houlton, S Akiki, R Gregg, M Rindl, J Khan, J Ward, ... Leukemia 29 (4), 988-991, 2015 | 35 | 2015 |
| Effects of intermittent fasting on response to tyrosine kinase inhibitors (TKIS) in patients with chronic myeloid leukemia: an outcome of european leukemianet project MA Yassin, RS Ghasoub, MB Aldapt, MA Abdulla, P Chandra, ... Cancer Control 28, 10732748211009256, 2021 | 29 | 2021 |
| Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells P Oblakowski, C Bello-Fernandez, JE Reittie, HE Heslop, G Galatowicz, ... | 29 | 1991 |
| Terminal deoxynucleotidyl transferase promotes acute myeloid leukemia by priming FLT3-ITD replication slippage J Borrow, SA Dyer, S Akiki, MJ Griffiths Blood, The Journal of the American Society of Hematology 134 (25), 2281-2290, 2019 | 27 | 2019 |
| Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t (14; 18) in autologous bone marrow from patients with follicular lymphoma, before … VI Pappa, S Wilkes, A Salam, BD Young, TA Lister, AZS Rohatiner Bone marrow transplantation 22 (6), 553-558, 1998 | 24 | 1998 |
| Molecular roulette: nucleophosmin mutations in AML are orchestrated through N-nucleotide addition by TdT J Borrow, SA Dyer, S Akiki, MJ Griffiths Blood, The Journal of the American Society of Hematology 134 (25), 2291-2303, 2019 | 23 | 2019 |
